Related Experiment Videos
Radioimmunoassay for human thymus-leukemia-associated antigen
Journal of the National Cancer Institute
|March 1, 1979
Summary
A new competitive radioimmunoassay accurately quantifies human thymus-leukemia-associated antigen (HThy-L). This method detects low HThy-L levels in thymocytes and lymphoblasts, crucial for understanding T-cell leukemia.
Area of Science:
- Immunology
- Biochemistry
- Oncology
Background:
- Human thymus-leukemia-associated antigen (HThy-L) is a key marker in certain leukemias.
- Accurate quantitation of HThy-L is essential for diagnostic and research purposes.
Purpose of the Study:
- To develop a sensitive and specific competitive radioimmunoassay for HThy-L quantitation.
- To characterize the HThy-L antigen and validate the assay's performance.
Main Methods:
- Development of antisera against purified HThy-L.
- Radioiodination of HThy-L using a modified lactoperoxidase technique.
- Purification and characterization of labeled HThy-L via Sephadex G-100 gel filtration and SDS-PAGE.
- Establishment of a competitive radioimmunoassay using the purified, labeled HThy-L.
Main Results:
- Two labeled components with molecular weights of 45,000 and 25,000 daltons were identified.
- The 45,000-dalton component was confirmed to possess HThy-L antigenicity.
- The developed assay could detect approximately 1 ng of HThy-L.
- Highest HThy-L concentrations were found in thymocytes, normal thymus tissue, and T-cell line lymphoblasts.
Conclusions:
- A robust competitive radioimmunoassay for HThy-L quantitation has been successfully developed.
- The assay demonstrates high sensitivity and specificity, enabling the detection of low antigen levels.
- This method provides a valuable tool for the quantitative analysis of HThy-L in biological samples, aiding in leukemia research.